Therefore, high expression of PCDHGB7 may lead to disorders in DNA damage repair and anti-tumor immune regulation, resulting in poor responsiveness of lung cancer patients to immunotherapy. This evidence concerns the gene PCDHGB7 and lung carcinoma.